2.0
Sep 11, 2014
Current employee, more than 8 years
New York, NY
Recommend
CEO approval
Business Outlook
Pros
Very diversified company. Good exposure to both Life Sciences and Industrial business. Benefits in general are good but the endless cost cutting is taking a toll.
Cons
Senior leadership's goals are clearly short term. Financial community seems to not notice the complete lack of a long term strategy. Benefits and resource cost cutting are being offset by excessive executive compensation.